JAVMA news
Canadian veterinary colleges teach access to care
Students at Ontario Veterinary College and Atlantic Veterinary College will graduate with a better understanding of how to remove barriers to access…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
JAVMA news
Coalition wants veterinary access for economically at-risk pets
An ongoing concern voiced by some in the profession is that nonprofit organizations providing veterinary services are competing
AVMA news
11 technologies veterinary practices can adopt today
New devices and software promise to help enhance patient care and monitoring, ease workloads, improve workflows, meet or exceed client expectations,…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
JAVMA news
Model law: Pharmacies should keep a reference on veterinary drugs
The National Association of Boards of Pharmacy recently amended the NABP Model State Pharmacy Act to require pharmacies that dispense
blog
Advocacy update: Illicit xylazine, retirement saving, and budget wins
What's happening in Washington, D.C., that affects you? The AVMA's Capitol Hill update outlines some of the most recent developments.
JAVMA news
CDC recommends veterinarians be prioritized for COVID-19 vaccines
As rollout continues, APHIS deploys veterinarians to help with the vaccination effort, some states consider having private practitioners help…
AVMA news
USP revised compounding standards go into effect
Revised compounding standards from the United States Pharmacopeia (USP) became effective November 1 after 12 years of work. According to the USP, the…
JAVMA news
AVMA lobbies Congress, virtually
The AVMA hosted its annual legislative fly-in April 21, bringing veterinary students and veterinarians together virtually with their members of…
AVMA news
AVMA webinars help veterinarians navigate opioid epidemic
Three new drug-related webinars are available on demand on AVMA Axon to help veterinarians meet their state’s continuing education (CE) requirements…
JAVMA news
Court rules FDA allowed to inspect pharmacies
The U.S. Court of Appeals for the Third Circuit ruled in September that the Food and Drug Administration has the authority to inspect pharmacies.
JAVMA news
Changing the rules for pharmacy
The ever-changing state and federal rules governing pharmacy within veterinary medicine were the subject of a wide-ranging session during the 2014…
JAVMA news
Vaccination, warnings ahead of Iditarod
A parvovirus outbreak in private sled dog kennels prompted warnings to mushers and vaccination efforts in rural villages before the Iditarod race in…
JAVMA news
Pfizer CEO and veterinarian Albert Bourla tells Penn Vet grads, ‘What we do matters’
Pfizer CEO and veterinarian Albert Bourla, in his commencement address to the University of Pennsylvania School of Veterinary Medicine Class of 2021,…
policy
Joint AVMA-FVE-CVMA statement on the global control of dog-mediated rabies: A One Health imperative
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
JAVMA news
New guidance for pets exposed to rabies
New guidance in this issue of the JAVMA advises that cats and dogs that are exposed to rabies and are overdue for a vaccine can have a booster shot…
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
AVMA news
Vaccine hesitancy gives some US dog, cat owners cold feet
The connection between attitudes toward human and pet vaccines and how those of some people are changing is forcing veterinary professionals to more…
Compounding: FAQs for veterinarians
Get answers to the compounding questions veterinarians most frequently ask the AVMA.
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…